Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuronetics (STIM) Total Current Liabilities (2017 - 2025)

Neuronetics (STIM) has disclosed Total Current Liabilities for 9 consecutive years, with $28.9 million as the latest value for Q3 2025.

  • On a quarterly basis, Total Current Liabilities rose 71.27% to $28.9 million in Q3 2025 year-over-year; TTM through Sep 2025 was $28.9 million, a 71.27% increase, with the full-year FY2024 number at $31.3 million, up 57.81% from a year prior.
  • Total Current Liabilities was $28.9 million for Q3 2025 at Neuronetics, up from $27.8 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $47.8 million in Q3 2021 to a low of $10.9 million in Q1 2021.
  • A 5-year average of $21.9 million and a median of $18.9 million in 2022 define the central range for Total Current Liabilities.
  • Peak YoY movement for Total Current Liabilities: plummeted 74.47% in 2021, then soared 111.42% in 2022.
  • Neuronetics' Total Current Liabilities stood at $15.7 million in 2021, then soared by 111.42% to $33.2 million in 2022, then plummeted by 40.32% to $19.8 million in 2023, then surged by 57.81% to $31.3 million in 2024, then dropped by 7.44% to $28.9 million in 2025.
  • Per Business Quant, the three most recent readings for STIM's Total Current Liabilities are $28.9 million (Q3 2025), $27.8 million (Q2 2025), and $24.8 million (Q1 2025).